Boston Common Asset Management, LLC Organon & Co. Transaction History

Boston Common Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$19.27 - $24.63 $203,086 - $259,575	-10,539 Reduced 3.9%	259,916 $5.41 Million
Q1 2023 May 17, 2023	SELL	$21.42 - $32.08 $63,146 - $94,571	-2,948 Reduced 1.08%	270,455 $6.36 Million
Q4 2022 Jan 26, 2023	BUY	$23.31 - $28.61 $391,538 - $480,562	16,797 Added 6.55%	273,403 $7.64 Million
Q3 2022 Oct 20, 2022	SELL	$23.4 - $34.25 $2.92 Million - $4.27 Million	-124,614 Reduced 32.69%	256,606 $6.01 Million
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $47,426 - $58,272	1,498 Added 0.39%	381,220 $12.9 Million
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $1.93 Million - $2.49 Million	63,317 Added 20.01%	379,722 $13.3 Million
Q4 2021 Jan 31, 2022	BUY	$28.67 - $37.13 $294,842 - $381,844	10,284 Added 3.36%	316,405 $9.63 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $2.5 Million - $3.11 Million	87,367 Added 39.94%	306,121 $10 Million
Q2 2021 Aug 19, 2021	BUY	$28.45 - $38.0 $6.22 Million - $8.31 Million	218,754 New	218,754 $6.62 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.